Daniel M. Huse, MA

home / authors / daniel-m-huse-ma

Articles

May 1st 2002

Impact of Leflunomide Versus Biologic Agents on the Costs of Care for Rheumatoid Arthritis in a Managed Care Population

Daniel A. Ollendorf, MPH Anna N. Peterson, BA Joseph Doyle, RPh, MBA Daniel M. Huse, MA

January 1st 2002

Use of Managed Care Claims Data in the Risk Assessment of Venous Thromboembolism in Outpatients

Mason W. Russell, MAPE Douglas C. A. Taylor, MBA Gordon Cummins, MS Daniel M. Huse, MA

January 1st 2002

Outpatient Treatment of Venous Thromboembolism with Low-Molecular-Weight Heparin: An Economic Evaluation

Daniel M. Huse, MA Gordon Cummins, MS Douglas C. A. Taylor, MBA Mason W. Russell, MAPE

September 1st 2000

Anti-inflammatory Therapy Reduces Total Costs of Asthma Care Compared with Bronchodilation: The Asthma Outcomes Registry

Daniel M. Huse, MA Mason W. Russell, MAPE Scott T. Weiss, MD, MS Stuart C. Hartz, ScD

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Colorectal cancer | Image credit: Dr_Microbe - stock.adobe.com

Published: October 7th 2024 | Updated: November 21st 2024

CRC Screening Increases in Patients Aged 45 to 49 After USPSTF Recommendation

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions